48 related articles for article (PubMed ID: 32323895)
1. Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells.
Wang L; Cao J; Wang X; Lin E; Wang Z; Li Y; Li Y; Chen M; Wang X; Jiang B; Zhang R; Sahoo N; Zhang X; Zhu XR; Myers JN; Frank SJ
Head Neck; 2020 Sep; 42(9):2244-2256. PubMed ID: 32323895
[TBL] [Abstract][Full Text] [Related]
2. Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and Niraparib.
Mentzel J; Hildebrand LS; Kuhlmann L; Fietkau R; Distel LV
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891817
[TBL] [Abstract][Full Text] [Related]
3. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Nowsheen S; Bonner JA; Yang ES
Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
[TBL] [Abstract][Full Text] [Related]
4. Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization.
Zhang Y; Liang L; Li Z; Huang Y; Jiang M; Zou B; Xu Y
Front Oncol; 2023; 13():1295579. PubMed ID: 38111536
[TBL] [Abstract][Full Text] [Related]
5. PARP inhibitors combined with radiotherapy: are we ready?
Sun C; Chu A; Song R; Liu S; Chai T; Wang X; Liu Z
Front Pharmacol; 2023; 14():1234973. PubMed ID: 37954854
[TBL] [Abstract][Full Text] [Related]
6. Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons.
Park S; Choi C; Kim H; Shin YJ; Oh Y; Park W; Cho WK; Kim N
Breast Cancer Res Treat; 2024 Feb; 203(3):449-461. PubMed ID: 37902934
[TBL] [Abstract][Full Text] [Related]
7. The Cellular Response to Complex DNA Damage Induced by Ionising Radiation.
Wilkinson B; Hill MA; Parsons JL
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902352
[TBL] [Abstract][Full Text] [Related]
8. GA-OH enhances the cytotoxicity of photon and proton radiation in HPV
Chitsike L; Bertucci A; Vazquez M; Lee S; Unternaehrer JJ; Duerksen-Hughes PJ
Front Oncol; 2023; 13():1070485. PubMed ID: 36845698
[TBL] [Abstract][Full Text] [Related]
9. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.
Papalouka C; Adamaki M; Batsaki P; Zoumpourlis P; Tsintarakis A; Goulielmaki M; Fortis SP; Baxevanis CN; Zoumpourlis V
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769087
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma.
Lei H; He A; Jiang Y; Ruan M; Han N
Front Oncol; 2022; 12():1031944. PubMed ID: 36338767
[TBL] [Abstract][Full Text] [Related]
11. Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons.
Bright SJ; Flint DB; Martinus DKJ; Turner BX; Manandhar M; Ben Kacem M; McFadden CH; Yap TA; Shaitelman SF; Sawakuchi GO
Radiat Res; 2022 Oct; 198(4):336-346. PubMed ID: 35939823
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy and the cellular DNA damage response: current and future perspectives on head and neck cancer treatment.
Fabbrizi MR; Parsons JL
Cancer Drug Resist; 2020; 3(4):775-790. PubMed ID: 35582232
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations.
Lee DW; Kim JE; Lee GH; Son A; Park HC; Oh D; Jo K; Choi C
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054773
[TBL] [Abstract][Full Text] [Related]
14. Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review.
Chitsike L; Duerksen-Hughes PJ
Front Oncol; 2021; 11():730412. PubMed ID: 34490123
[TBL] [Abstract][Full Text] [Related]
15. A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond.
Matsumoto Y; Fukumitsu N; Ishikawa H; Nakai K; Sakurai H
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442469
[TBL] [Abstract][Full Text] [Related]
16. Models for Translational Proton Radiobiology-From Bench to Bedside and Back.
Suckert T; Nexhipi S; Dietrich A; Koch R; Kunz-Schughart LA; Bahn E; Beyreuther E
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439370
[TBL] [Abstract][Full Text] [Related]
17. The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
Wang L; Fossati P; Paganetti H; Ma L; Gillison M; Myers JN; Hug E; Frank SJ
Int J Part Ther; 2021; 8(1):3-13. PubMed ID: 34285931
[TBL] [Abstract][Full Text] [Related]
18. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
Taku N; Wang L; Garden AS; Rosenthal DI; Gunn GB; Morrison WH; Fuller CD; Phan J; Reddy JP; Moreno AC; Spiotto MT; Chronowski G; Shah SJ; Mayo LL; Gross ND; Ferrarotto R; Zhu XR; Zhang X; Frank SJ
Curr Treat Options Oncol; 2021 Jun; 22(6):54. PubMed ID: 34086150
[TBL] [Abstract][Full Text] [Related]
19. PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts.
Weigert V; Jost T; Hecht M; Knippertz I; Heinzerling L; Fietkau R; Distel LV
BMC Cancer; 2020 Aug; 20(1):775. PubMed ID: 32811446
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
